Passive immunization with OMRI-hep-B for prevention of hepatitis B virus reinfection after liver transplantation

Transplantation Proceedings

Volumn 33, Issue 6, 2001, Pages 2895-2896

  Ben Ari, Z ^a,c   Mor, E ^b   Manhaim, V ^a   Barak, O ^a   Bar Nathan, N ^b   Shaharabani, E ^b   Shapira, Z ^b   Tur Kaspa, R ^a  

^a Liver Institute   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HYPERIMMUNE GLOBULIN; OMRI HEP B; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; MALE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REINFECTION;

ADULT; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS;

EID: 0034865809     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02240-0     Document Type: Conference Paper

References (4)

1. Samuel D, Muller R, Alexander G, et al: N Engl J Med 329:42, 1993
2. Terrault NA, Zhou S, Combs C, et al: Hepatology 24:1327, 1996
3. Adler R, Safadi R, Caraco Y, et al: Hepatology 29:1299, 1999
4. McGory RW, Ishitani MB, Oliveira WB, et al: Transplantation 61:1358, 1996